Literature DB >> 19502259

The insertion/deletion polymorphism of the angiotensin-converting enzyme gene is associated with progression, but not development, of albuminuria in Iranian patients with type 2 diabetes.

Abdolrahim Nikzamir1, Alireza Esteghamati, Mostafa Feghhi, Manouchehr Nakhjavani, Armin Rashidi, Javad Zavar Reza.   

Abstract

INTRODUCTION: The insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE) gene has been shown to be associated with a number of complications of type 2 diabetes.
RESULTS: on the development and progression of albuminuria, however, have remained controversial, with ethnic differences being a potential reason.The present study is the first report to examine Iranian patients.
METHODS: Patients (322; 162 males) with type 2 diabetes were categorised in this cross-sectional study into the following groups: normoalbuminuria (n=145), microalbuminuria (n=129) and macroalbuminuria (n=48).ACE gen I/D polymorphism genotypes were determined using the polymerase chain reaction method. RESULT: s. The distribution of ACE genotypes was significantly different among the groups (p<0.001), with the II genotype decreasing and the DD genotype increasing in frequency with increasing severity of albuminuria. Multivariate regression analysis showed that the ACE genotype did not change the odds of having microalbuminuria versus normoalbuminuria, while the D allele independently increased the odds of having macroalbuminuria versus microalbuminuria approximately threefold (p<0.01).
CONCLUSIONS: In Iranian patients with type 2 diabetes, the D allele is associated with progression, but not development, of albuminuria.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19502259     DOI: 10.1177/1470320309104872

Source DB:  PubMed          Journal:  J Renin Angiotensin Aldosterone Syst        ISSN: 1470-3203            Impact factor:   1.636


  8 in total

1.  ACE gene polymorphism and serum ACE activity in Iranians type II diabetic patients with macroalbuminuria.

Authors:  Vahid Felehgari; Zohreh Rahimi; Hadi Mozafari; Asad Vaisi-Raygani
Journal:  Mol Cell Biochem       Date:  2010-09-10       Impact factor: 3.396

2.  Implications of the angiotensin converting enzyme gene insertion/deletion polymorphism in health and disease: a snapshot review.

Authors:  Paul R Gard
Journal:  Int J Mol Epidemiol Genet       Date:  2010-03-20

3.  The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria.

Authors:  Zohreh Rahimi; Vahid Felehgari; Mehrali Rahimi; Hadi Mozafari; Kheirollah Yari; Asad Vaisi-Raygani; Mansour Rezaei; Shohreh Malek-Khosravi; Habibolah Khazaie
Journal:  Mol Biol Rep       Date:  2010-09-19       Impact factor: 2.316

Review 4.  ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy.

Authors:  Zohreh Rahimi
Journal:  J Nephropathol       Date:  2012-10-01

5.  ACE I/D gene polymorphism can't predict the steroid responsiveness in Asian children with idiopathic nephrotic syndrome: a meta-analysis.

Authors:  Tian-Biao Zhou; Yuan-Han Qin; Li-Na Su; Feng-Ying Lei; Wei-Fang Huang; Yan-Jun Zhao
Journal:  PLoS One       Date:  2011-05-18       Impact factor: 3.240

6.  Distribution of ACE insertion/deletion (I/D) polymorphism in Iranian populations.

Authors:  Mostafa Saadat
Journal:  Mol Biol Res Commun       Date:  2015-06

Review 7.  Angiotensin-converting enzyme insertion/deletion polymorphism contributes high risk for chronic kidney disease in Asian male with hypertension--a meta-regression analysis of 98 observational studies.

Authors:  Chin Lin; Hsin-Yi Yang; Chia-Chao Wu; Herng-Sheng Lee; Yuh-Feng Lin; Kuo-Cheng Lu; Chi-Ming Chu; Fu-Huang Lin; Sen-Yeong Kao; Sui-Lung Su
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

Review 8.  Association between Genetic Variants and Diabetes Mellitus in Iranian Populations: A Systematic Review of Observational Studies.

Authors:  Mehrnoosh Khodaeian; Samaneh Enayati; Ozra Tabatabaei-Malazy; Mahsa M Amoli
Journal:  J Diabetes Res       Date:  2015-10-26       Impact factor: 4.011

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.